Interventions of Interest:

  • resmetirom (Madrigal Pharmaceuticals, Inc.)
  • obeticholic acid (Ocaliva or “OCA”, Intercept Pharmaceuticals)  

For questions, please contact Liis Shea, Program Director, at lshea@icer.org.

View the Key Stakeholder List.